Evaluating the survival outcomes in clinical node stage 2 and 3 breast cancer patients with negative sentinel lymph node biopsy after neoadjuvant chemotherapy: sentinel lymph node biopsy alone vs. axillary lymph node dissection

Evaluating the survival outcomes in clinical node stage 2 and 3 breast cancer patients with negative sentinel lymph node biopsy after neoadjuvant chemotherapy: sentinel lymph node biopsy alone vs. axillary lymph node dissection

PurposeWith the advancement of neoadjuvant chemotherapy (NAC), the reliance on surgical removal of axillary for high-risk breast cancer is diminishing. However, there is a lack of data on the oncologic safety of sentinel lymph node biopsy (SNB) alone in patients with clinical node stages 2 and 3 who...

Full description

Saved in:
Bibliographic Details
Main Authors: Eunju Shin, Tae-Kyung Yoo, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Sae Byul Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Oncology
Subjects:
breast cancer
neoadjuvant chemotherapy
axillary surgery
sentinel lymph node biopsy
axillary lymph node dissection
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1563586/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items